財務情報
- Market Capitalization 434.59 M
- Employee 22
- Founded 2009
- CEO N/A
- Website www.enterabio.com
- Headquarter Israel
- FIGI UNKNOWN
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
7.76
売上高対価格比率
2 133.59
関連ティッカー
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2918 | ALLO Allogene Therapeutics, Inc. - Common Stock | 1.27 USD | -1.55% | -11.81% | -29.44% | +2.42% | 438.77 M USD | ||
| 2926 | NGNE Neurogene Inc. - Common Stock | 21.75 USD | +0.88% | -15.04% | -37.93% | -26.07% | 435.25 M USD | ||
| 2936 | PRTA Prothena Corporation plc - Ordinary Shares | 8.43 USD | +0.84% | +0.96% | -4.42% | -16.70% | 432.77 M USD | ||
| 2944 | ZURA Zura Bio Limited - Class A Ordinary shares | 4.47 USD | +5.67% | +6.18% | -14.04% | +23.48% | 428.36 M USD |